Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? (Q37613493)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 August 2009

Language	Label	Description	Also known as
English	Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?	scientific article published on 27 August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

based on heuristic

inferred from title

author name string

Mitchell Kamrava

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Michael B Bernstein

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kevin Camphausen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

James W Hodge

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

27 August 2009

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Molecular BioSystems

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1262-1270

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.1039%2FB911313B

21 January 2018

Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of tumour response to radiation by interleukin-2 gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different mechanisms between premitotic apoptosis and postmitotic apoptosis in X-irradiated U937 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immune response under stress: the role of HSP-derived peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells and tumor microenvironment: a dangerous liaison

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular characteristics of immunogenic cancer cell death.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-angiogenesis: making the tumor vulnerable to the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific recognition of cruciform DNA by nuclear protein HMG1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19823740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG0594-85

Identifiers

10.1039/B911313B

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19823740%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37613493&oldid=2096405269"